Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs & Therapy Perspectives
Metadata
Title
Serenoa repens: a phytotherapeutic agent for benign prostatic hypertrophy
Publication date
01-08-1997
Publisher
Springer International Publishing
Published in
Drugs & Therapy Perspectives / Issue 3/1997
Print ISSN: 1172-0360
Electronic ISSN: 1179-1977
DOI
https://doi.org/10.2165/00042310-199710030-00001

Other articles of this Issue 3/1997

Drugs & Therapy Perspectives 3/1997 Go to the issue

Practical Issues and Updates

Benign prostatic hypertrophy: decision-making programme useful

New Drugs and Disease Management

Early intravenous to oral switch therapy in community-acquired pneumonia is advantageous

New Drugs and Disease Management

Drug-induced delirium: diagnosis, management and prevention

Drug Reactions and Interaction

Anthracycline maintenance therapy limited by risk of cardiotoxicity